R
Regeneron Pharmaceuticals, Inc. (REGN)
737.71
0.00 (0.00%)

737.71
0.00 (0.00%)
This stock has a consensus price target of $850.27 based on the ratings of 30 analysts. The high is $1150.00 and the low is $587.00.
| Цель | Мин. целевая цена | Средн. целевая цена | Макс. целевая цена |
|---|---|---|---|
| Цена | $ 587 | $ 850.27 | $ 1150 |
| Изменение | -20.43% | 15.26% | 55.89% |
| Дата | Потенциал роста/падения | Аналитическая компания | Целевая цена | Изменение рейтинга | Рейтинг |
|---|---|---|---|---|---|
| 2026-03-06 | 25.12% | Barclays | $923 | Initiates Coverage On | Overweight |
| 2026-03-02 | 3.7% | RBC Capital | $745 → $765 | Maintains | Sector Perform |
| 2026-02-09 | 32.17% | Guggenheim | $865 → $975 | Maintains | Buy |
| 2026-02-02 | 28.78% | JP Morgan | $850 → $950 | Maintains | Overweight |
| 2026-02-02 | 17.25% | Oppenheimer | $750 → $865 | Reiterates | Outperform |